@article{maillard:hal-03789849,
TITLE = {Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency},
AUTHOR = {Maillard, Maud and Launay, Manon and Royer, Bernard and Guitton, J{\'e}rome and Gautier-Veyret, Elodie and Broutin, Sophie and Tron, Camille and Le Louedec, F{\'e}licien and Ciccolini, Joseph and Richard, Damien and Alarcan, Hugo and Haufroid, Vincent and Tafzi, Na{\"i}ma and Schmitt, Antonin and Etienne-Grimaldi, Marie-Christine and Narjoz, C{\'e}line and Thomas, Fabienne},
URL = {https://hal.science/hal-03789849},
JOURNAL = {British Journal of Clinical Pharmacology},
PUBLISHER = {Wiley},
SERIES = {Global Pharmacovigilance},
VOLUME = {89},
NUMBER = {5},
PAGES = {762-772},
YEAR = {2022},
DOI = {10.1111/bcp.15536},
KEYWORDS = {dihydropyrimidine dehydrogenase ; dihydrouracil ; intra-individual variability ; pre-analytical practices ; uracil},
PDF = {https://hal.science/hal-03789849/file/MAILLARD_2022.pdf},
HAL_ID = {hal-03789849},
HAL_VERSION = {v1},
}